Myopathie de Duchenne - Publications Scientifiques

Dernière publication 08/11/2023

Dimethyl fumarate modulates the dystrophic disease program following short-term

New medicines are urgently required to treat the fatal neuromuscular disease Duchenne muscular dystrophy (DMD). Dimethyl fumarate (DMF) is a potent...

Array
(
    [id_prestablog_news] => 1893
    [id_shop] => 1
    [date] => 2023-11-08 00:00:00
    [date_modification] => 2024-02-09 14:15:13
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 3465
    [id_lang] => 2
    [title] => Dimethyl fumarate modulates the dystrophic disease program following short-term 
    [paragraph] => Dimethyl fumarate modulates the dystrophic disease program following short-term treatment
    [content] => 

Authors
itenis EJ, Sahakian L, Debrincat D, Stupka N, Hafner P, Arthur PG, Terrill JR, Apostolopoulos V, de Haan JB, Guven N, Fischer D, Rybalka E.


Lab
Victoria University, Melbourne, Victoria, Australia

Journal
JCI Insight

Abstract
New medicines are urgently required to treat the fatal neuromuscular disease Duchenne muscular dystrophy (DMD). Dimethyl fumarate (DMF) is a potent immunomodulatory small molecule nuclear erythroid 2-related factor 2 activator with current clinical utility in the treatment of multiple sclerosis and psoriasis that could be effective for DMD and rapidly translatable. Here, we tested 2 weeks of daily 100 mg/kg DMF versus 5 mg/kg standard-care prednisone (PRED) treatment in juvenile mdx mice with early symptomatic DMD. Both drugs modulated seed genes driving the DMD disease program and improved force production in fast-twitch muscle. However, only DMF showed pro-mitochondrial effects, protected contracting muscles from fatigue, improved histopathology, and augmented clinically compatible muscle function tests. DMF may be a more selective modulator of the DMD disease program than PRED, warranting follow-up longitudinal studies to evaluate disease-modifying impact.

BIOSEB Instruments Used
Grip strength test (BIO-GS4)

[meta_description] => [meta_keywords] => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721277/ [meta_title] => [link_rewrite] => dimethyl-fumarate-modulates-the-dystrophic-disease-program-following-short-term-treatment [actif_langue] => 1 [read] => 499 [count_comments] => 0 [id] => 1893 [categories] => Array ( [44] => Array ( [id_prestablog_categorie] => 44 [title] => Myopathie de Duchenne [link_rewrite] => Myopathie-de-Duchenne ) [2] => Array ( [id_prestablog_categorie] => 2 [title] => Publications [link_rewrite] => publications ) ) [authors] => [paragraph_crop] => Dimethyl fumarate modulates the dystrophic disease program following short-term treatment [link_for_unique] => 1 [products_liaison] => Array ( [48] => Array ( [name] => Test d'agrippement [description_short] =>

Une méthode simple pour quantifier objectivement la force musculaire des rats et souris et l'effet de drogues, toxines, maladies musculaires (ex: myopathie) et neurodégénératives. Cette mesure de force est souvent employée en association avec le test de coordination motrice ROTAROD: un sujet présentant une coordination normale montrera des résultats médiocres en cas de faible force musculaire. Un must pour vos recherches sur l'activité, la coordination et le contrôle musculaire: particulièrement utile pour vos études sur les maladies de Parkinson et Huntington.

Nouveautés GS4 - 2023: Écran couleur rétroéclairé (meilleure lisibilité), pédale de remise à zéro, durée de batterie optimisée, taille de mémoire augmentée à 500 valeurs, compteur d'animaux, port USB (transfert de données/charge)

Instrument for ratsInstrument for mice

[thumb] => [img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg [image_presente] => 1 [link] => https://preprod.bioseb.com/fr/activite-systeme-moteur-coordination/48-grip-strength-test.html ) ) ) 1
En lire plus

Filtres

Applications

Dates

<< 1 2 >>